Printer Friendly
The Free Library
14,679,069 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ZIOPHARM to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- ZIOPHARM Oncology, Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB: ZIOP) announced today that Dr. Jonathan Lewis For the England international cricketer who plays for Gloucestershire, please see Jon Lewis and for the American football player, see Jonathan Lewis (football player).
Jonathan James Benjamin Lewis (born 21 May 1970, Isleworth, Middlesex, England) is a former English cricketer.
, Chief Executive Officer, will present at the Rodman & Renshaw 3rd Annual Healthcare Conference on Tuesday, May 16, 2006 at 10:30 am GMT (Greenwich Mean Time) See UTC.

GMT - Universal Time 1
+1 at Le Meridien Beach Plaza Hotel The Plaza Hotel in New York City is a landmark 19-story luxury hotel with a height of 250 feet (76 m) and length of 400 feet that (122 m) occupies the west side of Grand Army Plaza, from which it derives its name, and extends along Central Park South in Manhattan.  in Monte Carlo Monte Carlo (môNtā` kärlō`), town (1982 pop. 13,150), principality of Monaco, on the Mediterranean Sea and the French Riviera. , Monaco. Dr. Lewis will provide an overview of the Company and an update on its clinical development programs.

The presentation will be webcast live and can be accessed by visiting the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 section at www.ziopharm.com. The webcast will be archived for ninety days.

About ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment. For more information, visit www.ziopharm.com.

Forward-Looking Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement:

This press release contains forward-looking statements for ZIOPHARM Oncology, Inc. that involve risks and uncertainties that could cause the Company's actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. Among other things, there can be no assurance that any of the Company's development efforts relating to its product candidates will be successful, or such product candidates will be successfully commercialized. Other risks that affect forward-looking information contained in this press release include the possibility of being unable to obtain regulatory approval of the Company's product candidates, the risk that the results of clinical trials may not support the Company's claims, and risks related to the Company's ability to protect its intellectual property and its reliance on third parties to develop its product candidates. The Company assumes no obligation to update these forward-looking statements, except as required by law.

ZIOPHARM to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 9, 2006
Words:354
Previous Article:Comtech Telecommunications Corp. Receives $1.7 Million Satcom Equipment Order from DataPath to Support Government Program.
Next Article:LogicLibrary Selected by Norway's Largest Life Insurance Company to Manage and Reuse Key Software Services; Design-time Governance Leader Continues...
Topics:



Related Articles
ZIOPHARM Oncology to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference.
Callisto to Present Leading Anti-Cancer Drug Candidates at Rodman & Renshaw Healthcare Conference in Monaco; CEO Dr. Gary Jacob to Discuss Latest...
Novelos Therapeutics to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference.
CombinatoRx to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference.
GenVec to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference.
ChemGenex To Present At Rodman & Renshaw 3rd Annual Global Healthcare Conference.
The Immune Response Corporation to Present at Rodman & Renshaw Techvest Global Healthcare Conference 2006.
Presentation Alert: Aethlon Medical Presentation at Rodman & Renshaw Conference To Be Webcast ``Live'' on Monday, June 19th.
ZIOPHARM Oncology to Present at Rodman & Renshaw Annual Healthcare Conference.
ZIOPHARM to Present at Rodman & Renshaw 4th Annual Global Healthcare Conference.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles